Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.12M | -8.07M | -9.90M | -5.63M | -6.92M |
| Total Depreciation and Amortization | 89.70K | 75.80K | 28.10K | 28.10K | 28.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.62M | 5.45M | 6.87M | 4.14M | 5.18M |
| Change in Net Operating Assets | 1.70M | 693.40K | 1.87M | 731.20K | 810.90K |
| Cash from Operations | -705.90K | -1.86M | -1.13M | -732.40K | -899.20K |
| Capital Expenditure | -- | -- | 0.00 | -4.50K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -4.50K | 0.00 |
| Total Debt Issued | 1.09M | 2.25M | 1.71M | 1.01M | 2.27M |
| Total Debt Repaid | -369.70K | -466.20K | -505.70K | -290.20K | -1.63M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 50.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 716.90K | 1.78M | 1.21M | 717.20K | 685.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.00K | -78.10K | 76.00K | -19.70K | -214.00K |